Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

RPR's docetaxel now approved in 49 countries

Feb. 7, 1997

Another Isis antisense compound to enter clinic

Feb. 7, 1997

Isis previews antisense anticancer program

Feb. 7, 1997

Follow-up data reported for Amelorad

Feb. 7, 1997

Merck describes improved chemotherapeutic agents

Feb. 7, 1997

Whole-body hyperthermia therapy enters clinic for new indication

Feb. 6, 1997

Sugen's TK antagonist enters phase II

Feb. 6, 1997

Antitumor prodrugs for ADEPT from Pharmachemie

Feb. 6, 1997

ChiRex and Cell Therapeutics sign supply agreement

Feb. 5, 1997

GeneMedicine IND approved

Feb. 4, 1997